Ensemble survival trees for identifying subpopulations in personalized medicine.
暂无分享,去创建一个
[1] A. Ciampi,et al. Stratification by stepwise regression, correspondence analysis and recursive partition: A comparison of three methods of analysis for survival data with covaria , 1986 .
[2] R. Simon,et al. The Cross-Validated Adaptive Signature Design , 2010, Clinical Cancer Research.
[3] Claudio Conversano,et al. Combining an Additive and Tree-Based Regression Model Simultaneously: STIMA , 2010 .
[4] K. Hornik,et al. Model-Based Recursive Partitioning , 2008 .
[5] S. P. Lloyd,et al. Least squares quantization in PCM , 1982, IEEE Trans. Inf. Theory.
[6] R. Olshen,et al. Tree-structured survival analysis. , 1985, Cancer treatment reports.
[7] J. Minna,et al. A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients , 2013, Clinical Cancer Research.
[8] Iven Van Mechelen,et al. A comparison of five recursive partitioning methods to find person subgroups involved in meaningful treatment–subgroup interactions , 2013, Advances in Data Analysis and Classification.
[9] R. Temple,et al. Enrichment designs: efficiency in development of cancer treatments. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Denis Larocque,et al. A review of survival trees , 2011 .
[11] Daniel J Sargent,et al. Clinical trial designs for predictive marker validation in cancer treatment trials. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Igor Jurisica,et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Xiaogang Su,et al. Subgroup Analysis via Recursive Partitioning , 2009 .
[14] M. LeBlanc,et al. Relative risk trees for censored survival data. , 1992, Biometrics.
[15] J. M. Taylor,et al. Subgroup identification from randomized clinical trial data , 2011, Statistics in medicine.
[16] R. Simon,et al. Adaptive Signature Design: An Adaptive Clinical Trial Design for Generating and Prospectively Testing A Gene Expression Signature for Sensitive Patients , 2005, Clinical Cancer Research.
[17] Seng-Jaw Soong,et al. An Integrated Tree-Based Classification Approach to Prognostic Grouping with Application to Localized Melanoma Patients , 2007, Journal of biopharmaceutical statistics.
[18] John Crowley,et al. Developing and Validating Continuous Genomic Signatures in Randomized Clinical Trials for Predictive Medicine , 2012, Clinical Cancer Research.
[19] Daniel J Sargent,et al. Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All , 2009, Journal of biopharmaceutical statistics.
[20] R B Davis,et al. Exponential survival trees. , 1989, Statistics in medicine.
[21] Ralf Bender,et al. Generating survival times to simulate Cox proportional hazards models , 2005, Statistics in medicine.
[22] A. Nádas. On Estimating the Distribution of a Random Vector When Only the Smallest Coordinate Is Observable , 1970 .
[23] Mark R. Segal,et al. Regression Trees for Censored Data , 1988 .
[24] Daniel J Sargent,et al. Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Dung-Tsa Chen,et al. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer. , 2011, Journal of the National Cancer Institute.
[26] Richard Simon,et al. Evaluation of randomized discontinuation design. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] I. Lipkovich,et al. Subgroup identification based on differential effect search—A recursive partitioning method for establishing response to treatment in patient subpopulations , 2011, Statistics in medicine.